Immune-related adverse events (IrAEs) as a predictor of response to immunotherapy in patients with lung cancer

被引：0
|
作者：
Sanchez Becerra, M. V. [1 ]
Martinez-Cabanes, R. [1 ]
Gonzalez-Lopez, A. [1 ]
Zhan-Zhou, E. [2 ]
Sotelo, V. [1 ]
Esteban, M. [1 ]
Robles, T. [1 ]
Camara, J. C. [1 ]
Cardena, A. [1 ]
Hernando, S. [1 ]
Hurtado, A. [2 ]
Moreno, D. [1 ]
Olier, C. [1 ]
Mielgo Rubio, X. [1 ]
机构：
[1] Hosp Univ Fdn Alcorcon, Med Oncol, Alcorcon, Spain
[2] Hosp Univ Fdn Alcorcon, Alcorcon, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
204P
引用
收藏
页码：S808 / S809
页数：2
相关论文
共 50 条
  • [1] Focus on immune-related adverse events (irAEs) in immunotherapy of hepatobiliary malignancies
    Zhang, Lei
    Zhao, Haitao
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (03) : 348 - 349
  • [2] Placebo immune-related adverse events (irAEs): A neglected phenomenon in cancer immunotherapy trials
    Zhou, Yixin
    Yu, Hui
    Chen, Chen
    Li, Anlin
    Zhang, Xuanye
    Qiu, Huijuan
    Du, Wei
    Fu, Sha
    Zhang, Li
    Hong, Shaodong
    EUROPEAN JOURNAL OF CANCER, 2024, 208
  • [3] Evaluating immune-related adverse events (irAEs) in a real-world cohort with lung cancer receiving immunotherapy
    Hu, Xiao
    Pan, Stacey
    Salei, Yana V.
    Lin, Jeffrey H.
    Parsons, Susan K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E32 - E32
  • [4] Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy
    Ezponda Casajus, A.
    Calvo Imirizaldu, M.
    de Torres Tajes, J. P.
    Garcia-Baizan, A.
    Castanon Alvarez, E.
    Cano Rafart, D.
    Vivas Perez, I
    Bastarrika Aleman, G.
    RADIOLOGIA, 2020, 62 (02): : 131 - 138
  • [5] Immune-Related Adverse Events (irAEs) of Nivolumab Predicts Clinical Benefit in Advanced Lung Cancer Patients
    Toi, Y.
    Sugawara, S.
    Kawashima, Y.
    Aiba, T.
    Tsurumi, K.
    Suzuki, K.
    Shimizu, H.
    Sugisaka, J.
    Ono, H.
    Domeki, Y.
    Kawana, S.
    Saito, R.
    Terayama, K.
    Nakamura, A.
    Yamanda, S.
    Kimura, Y.
    Honda, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2417 - S2417
  • [6] The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapy
    Calabrese, Leonard
    Mariette, Xavier
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (02) : 162 - 164
  • [7] Immune-Related Adverse Events in Patients with Lung Cancer
    Guilherme Sacchi de Camargo Correia
    Tanmayi Pai
    Shenduo Li
    Dana Connor
    Yujie Zhao
    Yanyan Lou
    Rami Manochakian
    Current Oncology Reports, 2023, 25 : 1259 - 1275
  • [8] Immune-Related Adverse Events in Patients with Lung Cancer
    Correia, Guilherme Sacchi de Camargo
    Pai, Tanmayi
    Li, Shenduo
    Connor, Dana
    Zhao, Yujie
    Lou, Yanyan
    Manochakian, Rami
    CURRENT ONCOLOGY REPORTS, 2023, 25 (11) : 1259 - 1275
  • [9] Diagnosis and Management of Immune Related Adverse Events (irAEs) in Cancer Immunotherapy
    Liu, Yi-He
    Zang, Xin-Yuan
    Wang, Jin-Cheng
    Huang, Shan-Shan
    Xu, Jiang
    Zhang, Peng
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 120
  • [10] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
12345